Back
Crinetics Pharmaceuticals Stock Predictions
Sponsored
CRNX
Sponsored
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Buy
60
CRNX
Crinetics Pharmaceuticals
Last Price:
59.57
Seasonality Move:
9.3%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE TradeCrinetics Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Crinetics Pharmaceuticals has on average historically risen by 30.3% based on the past 6 years of stock performance.
- Crinetics Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Crinetics Pharmaceuticals Stock Undervalued?
The current Crinetics Pharmaceuticals [CRNX] share price is $58.92. The Score for CRNX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal. - CRNX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Crinetics Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Crinetics Pharmaceuticals has on average historically risen by 30.3% based on the past 6 years of stock performance.
Crinetics Pharmaceuticals Stock Rating
Buy
60
Crinetics Pharmaceuticals (CRNX)
is a Buy
Is Crinetics Pharmaceuticals overpriced?
- Crinetics Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Crinetics Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
crinetics.com
52-Week Data
52-Week High:
62.00
52-Week Low:
27.55
Prediction Charts
Market Cap:
4.72B
Price in USD:
58.92
Volume:
1.14M
Beta:
0.68
Technical Analysis
SMA50:
54.58
SMA100:
52.68
SMA200:
48.24
52-Wk Change:
108.35%
Stock Predictions
-
Is Crinetics Pharmaceuticals stock public?
Yes, Crinetics Pharmaceuticals is a publicly traded company. -
What is the Crinetics Pharmaceuticals stock quote today?
The Crinetics Pharmaceuticals stock price is 58.92 USD today. -
How to buy Crinetics Pharmaceuticals stock online?
You can buy Crinetics Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-25 | 59.22 | 57.96 | 59.32 | 57.86 |
Oct-28 | 58.64 | 57.15 | 59.67 | 56.82 |
Oct-29 | 56.84 | 56.26 | 57.24 | 56.12 |
Oct-30 | 55.91 | 55.76 | 56.96 | 55.43 |
Oct-31 | 55.36 | 55.98 | 56.54 | 54.32 |
Nov-1 | 56.50 | 56.69 | 57.81 | 56.19 |
Nov-4 | 56.17 | 56.82 | 58.00 | 55.21 |
Nov-5 | 56.49 | 57.81 | 57.88 | 55.28 |
Nov-6 | 60.03 | 59.16 | 60.91 | 58.58 |
Nov-7 | 59.11 | 59.75 | 60.17 | 58.66 |
Nov-8 | 59.60 | 60.69 | 60.93 | 58.98 |
Nov-11 | 61.88 | 60.01 | 62.00 | 59.95 |
Nov-12 | 59.99 | 58.78 | 60.48 | 58.21 |
Nov-13 | 60.00 | 58.92 | 61.16 | 58.50 |
Crinetics Pharmaceuticals Earnings
Crinetics Pharmaceuticals Earnings Report: Per Share Crinetics Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Crinetics Pharmaceuticals Forecast Revenue Growth
Crinetics Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Crinetics Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.21 per share.
* Crinetics Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.